Showing results (461-470 of 554) with videos related to
Sort By:
Pageof 56
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|November 8, 2024
A Novel Delivery Approach of Clinical Inner Ear Gene TherapyLong Long Zhang, JingHan Wang, Zi Wen Gao, et al.JAMA Surgery|March 12, 2025
Prognostic Impact of Fluorescent Lymphography on Gastric Cancer After Neoadjuvant ChemotherapyYi-Hui Tang, Ze-Ning Huang, Yu-Qin Sun, et al.BMC Cancer|November 8, 2019
Risk factors of lymph node metastasis or lymphovascular invasion for early gastric cancer: a practical and effective predictive model based on international multicenter dataJian-Xian Lin, Zu-Kai Wang, Wei Wang, et al.Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|February 11, 2019
The predictive value of the preoperative C-reactive protein-albumin ratio for early recurrence and chemotherapy benefit in patients with gastric cancer after radical gastrectomy: using randomized phase III trial dataBin-Bin Xu, Jun Lu, Zhi-Fang Zheng, et al.Molecular Cancer|July 12, 2020
m6A modification-mediated BATF2 acts as a tumor suppressor in gastric cancer through inhibition of ERK signalingJian-Wei Xie, Xiao-Bo Huang, Qi-Yue Chen, et al.Journal of Cancer|April 15, 2020
Multicenter Validation Study of the American Joint Commission on Cancer (8th Edition) for Gastric Cancer: Proposal for a Simplified and Improved TNM Staging SystemJian-Xian Lin, Jacopo Desiderio, Jun-Peng Lin, et al.Frontiers in Oncology|August 13, 2021
Prognostic Value of Tumor Regression Grading in Patients Treated With Neoadjuvant Chemotherapy Plus Surgery for Gastric CancerJian-Wei Xie, Jun Lu, Bin-Bin Xu, et al.The New England Journal of Medicine|October 19, 2012
Ustekinumab induction and maintenance therapy in refractory Crohn's diseaseWilliam J Sandborn, Christopher Gasink, Long-Long Gao, et al.JAMA Dermatology|December 11, 2024
Improving Diversity in a Novel Psoriasis Study: VISIBLE as a Framework for Clinical Trial Quality ImprovementAndrew Alexis, Amy McMichael, Neelam Vashi, et al.International Journal of Surgery (London, England)|December 20, 2023
Characterization changes and research waste in randomized controlled trials of global bariatric surgery over the past 20 years: cross-sectional studyZe-Ning Huang, Wen-Wu Qiu, Qi-Chen He, et al.Pageof 56